Factor V  G1691A is associated with an increased risk of retinal vein occlusion: a meta-analysis

Yuanyuan Zou; Xi Zhang; Jingyi Zhang; Xiangning Ji; Yuqing Liu

doi:10.18632/oncotarget.20636

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Meta-Analysis:

Factor V G1691A is associated with an increased risk of retinal vein occlusion: a meta-analysis

Yuanyuan Zou _, Xi Zhang, Jingyi Zhang, Xiangning Ji and Yuqing Liu

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:75467-75477. https://doi.org/10.18632/oncotarget.20636

Metrics: PDF 1143 views | HTML 1807 views | ?

Abstract

Yuanyuan Zou1, Xi Zhang1, Jingyi Zhang1, Xiangning Ji1 and Yuqing Liu1

1The Second Department of Ophthalmology, Cangzhou Central Hospital, 061001, Cangzhou, PR China

Correspondence to:

Yuanyuan Zou, email: [email protected]

Keywords: factor V, retinal vein occlusion, polymorphism, meta-analysis

Received: June 27, 2017 Accepted: August 17, 2017 Published: September 04, 2017

ABSTRACT

We performed a meta-analysis to investigate the association between the Factor V G1691A polymorphism and the risk of retinal vein occlusion (RVO). This analysis included 37 studies involving 2,510 cases and 3,466 controls. Factor V G1691A was associated with an increased risk of RVO in the allele, heterozygote, dominant, and carrier models (PA < 0.001, odds ratios >1), but not the homozygote or recessive models (PA > 0.05). Similar results were observed in a meta-analysis of central retinal vein occlusion (CRVO) and when comparing Caucasian subgroups to population-based controls. These data demonstrate that the G/A genotype of Factor V G1691A is associated with an increased risk of RVO/CRVO in a Caucasian population.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20636

Publication Alerts

Meta-Analysis:

Factor V G1691A is associated with an increased risk of retinal vein occlusion: a meta-analysis

Abstract